Addition of Gabapentin to Opioids Does Not Improve Pain in
Patients with Chronic Neck and Low Back Pain
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Objective

We compared the reduction in pain and opioid
consumption in patients with chronic spinal pain on
concomitant gabapentinoids and opioids with patients
using opioids only.

Methods

• Design: This was a retrospective chart review of
patients with chronic neck or low back pain who were
on opioids with at least a 24-month follow-up.
• Setting: Single-center pain clinic in an urban setting.
• Subjects: 167 patients with chronic spinal pain
lasting at least six months Table 1.
• This study was approved by Advocate Healthcare
Institutional Review Board (#6985).
• Patients on gabapentin or pregabalin were included in
the gabapentinoid group, while the other patients
were included in the non-gabapentinoid group.
• Primary outcome was assessment of pain scores
measured via a numeric rating scale (NRS), and
secondary outcomes were response to the treatment
(>2 point reduction on NRS) and daily opioid use
measured in morphine milliequivalents.

Results

• Pain scores were reduced in the first six months and
plateaued after that in both groups. At the end of 24
months, the average pain score was 6.71 in the
gabapentinoid group, while the average pain score
was 7.18 in the non gabapentinoid group Figure 1.
• There was no statistical significance between the
groups (p=0.28).
• There was no difference in response to treatment in
gabapentinoid group (33.3%) when compared with
non-gabapentinoid group (32.7%) Table 2.
• We also failed to find any significant difference in
daily opioid usage between the two groups Table 3,
Figure 2.

Conclusion

Gabapentinoids may not lead to reduction in pain or
opioid consumption in patients with chronic spinal pain.
A careful approach must be adopted while prescribing
gabapentinoids in the chronic spinal pain patient
population.

Figure 1. Difference in pain scores between gabapentin vs non-gabapentin group
throughout 24-month follow-up.
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Figure 2. Percentage of different opioids prescribed to the patients.

